Business Wire

CA-SERVICENOW,-INC.

15.4.2020 15:32:06 CEST | Business Wire | Press release

Share
ServiceNow Makes No Layoff Pledge for 2020

ServiceNow (NYSE: NOW), the leading digital workflow company that makes work, work better for people, is committing to protect the jobs of its 11,000-plus global workforce through 2020 despite the economic uncertainty of the COVID-19 pandemic. The company also expects to keep hiring for new jobs worldwide this year. In addition, ServiceNow expects to continue to protect the jobs and salaries of several hundred support staff and contractors who are not working while ServiceNow’s offices remain closed.

“We want our employees focused on supporting our customers, not worried about their own jobs,” said Bill McDermott, ServiceNow’s CEO. “We are committed to no layoffs for 2020. We are continuing to hire worldwide.”

“We are grateful to be in this position,” McDermott continued. “Keeping our company strong means we can help our customers succeed. Supporting our customers, we can help get the U.S. and global economy working again. More than ever, companies see that creating great workflow-designed experiences help protect revenue and growth, provide business continuity and drive productivity. These are the priorities for every company now. We are all in this together.”

ServiceNow has continued to hire and onboard new employees throughout the COVID-19 pandemic. The company expects to create and fill more than 1,000 new jobs in the U.S., and more worldwide, by the end of 2020. Additionally, this summer the company will welcome approximately 360 college interns from around the world to work across its business. As a digital workflow company, ServiceNow has been able to quickly pivot to a digital internship program, maintaining the ability to provide college interns valuable career experience, even if employees continue to operate in a work-from-home environment. ServiceNow’s employees worldwide have been working from home since mid-March and expect to continue to do so until June 1.

Caroline Parkinson, a 2021 expected graduate of the University of Michigan who will join ServiceNow’s internship program this summer, said: “ServiceNow saved my summer. Without their digital intern program, I would have had to scramble to find a new summer job. Knowing that ServiceNow is determined to make my internship as enriching as possible during this uncertain time reaffirms my decision to join this company.”

Additionally, ServiceNow, along with Accenture, Lincoln Financial Group, and Verizon, this week announced People+Work Connect , a collaborative online employer-to-employer initiative that will bring together companies with workforces laid off or furloughed due to COVID-19 with those in urgent need of workers. More than 800 ServiceNow jobs will be posted through this collaborative effort. At no charge for employers to join and participate, the initiative is intended to help shorten the complex, lengthy cycle of finding new employment. For more information, visit: https://peopleworkconnect.accenture.com/welcome .

Helping our Customers Respond to COVID-19

ServiceNow is continuing to work aggressively to support its customers during this challenging time, including helping local, state and federal agencies better manage and coordinate emergency response efforts by utilizing ServiceNow’s digital workflow platform technology and no-charge COVID-19 emergency response applications.

Washington State’s Department of Health, a ServiceNow customer, initially created the Emergency Response Operations app on the Now Platform to manage their own response to COVID-19. Working with ServiceNow, the Department of Health has made the app available to all government entities at no charge.

In addition to the State of Washington’s Emergency Response Operations app, ServiceNow recently developed and introduced three, no-charge community apps: Emergency Outreach App, Emergency Self Report App and Emergency Exposure Management app. These community apps are part of a broader Customer Care Plan launched by ServiceNow in March to support its customers as they focus on maintaining business operations during the COVID-19 pandemic.

Examples of organizations leveraging ServiceNow to support their COVID-19 efforts include:

  • The City of Los Angeles , which was able to implement drive-through COVID-19 testing using the Now Platform. Within 48 hours of deployment, the City pushed their portal live to 16 million citizens who can now research and verify symptoms, schedule an appointment and choose a drive-through testing location.
  • The Calgary Catholic School District , which used the Now Platform to enable staff with links to critical information for a seamless, rapid transition from teaching in the classroom to educating from home. This continued student learning was made possible because of the simplified employee experience made available to their teacher.
  • A US retail company , that was able to rapidly respond to the influx of human resources cases for emergency paid leave requests due to COVID-19 by using the Now Platform. Within 96 hours, a mobile application was built and deployed to 330,000 employees globally.
  • A large City in the U.S. , which deployed an application on the Now Platform to assist 1.8 million of its citizens in need of food and distribution of other necessities during the COVID-19 pandemic.

“We deeply believe that technology should be in the service of people, and right now that means our responsibility is to help flatten the curve and aid other global organizations in continuing their own valuable work, employment and growth of their workforces,” McDermott said. “ServiceNow is committed to relentless innovation and protecting and creating jobs, to help us all emerge from this pandemic as a stronger community.”

More information about ServiceNow’s customer care plan, including accessing the community apps, can be found at servicenow.com/crisisresponse .

ServiceNow and its employees also have committed $1.5 million in cash donations to help COVID-19 response efforts. ServiceNow will make $1.225 million in corporate grants to the United Nations Foundation; the Centers for Disease Control Foundation; the NYC Mayor’s COVID-19 Emergency Relief Fund; the Silicon Valley Community Foundation COVID-19 Coronavirus Response Funds; and Second Harvest of Silicon Valley. Employee matching gift campaigns will raise additional funds to benefit non-profits in the local communities where our employees live and work.

Forward-Looking Statements

This press release contains forward‑looking statements relating to ServiceNow’s headcount, hiring and workforce expectations and plans. Such forward‑looking statements include, but are not limited to, statements that contain words such as expects, intends, aims or similar words conveying that the information is not historical fact. These statements reflect the current beliefs of ServiceNow and are based on current information available to ServiceNow as of the date hereof. Forward‑looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual outcomes and results to differ materially from those expected or implied by the forward‑looking statements. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our outcomes and results could differ materially from the those expressed or implied by the forward-looking statements ServiceNow makes. Factors that may cause actual outcomes and results to differ materially from those in any forward-looking statements include, without limitation, changes to global economic conditions and changes in the severity of the COVID-19 pandemic and its impact on our customers, partners or vendors. ServiceNow undertakes no obligation, and does not intend, to update these forward-looking statements after the date on which they are made.

About ServiceNow

ServiceNow (NYSE: NOW) is making the world of work, work better for people. Our cloud‑based platform and solutions deliver digital workflows that create great experiences and unlock productivity for employees and the enterprise. For more information, visit: www.servicenow.com .

© 2020 ServiceNow, Inc. All rights reserved. ServiceNow, the ServiceNow logo, Now, and other ServiceNow marks are trademarks and/or registered trademarks of ServiceNow, Inc. in the United States and/or other countries. Other company names, product names, and logos may be trademarks of the respective companies with which they are associated.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye